insights_auto
Why is AKBA down 5,33%?
Dive Deeperchevron_right
AKBA:NASDAQ
Akebia Therapeutics Inc
0,87 US$
arrow_downward
-5,33%(-0,049) 1D
0,88 US$
arrow_upward
+0,65% (+0,0057)todayPre-market
Closed: 1 ოქტ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AKBA...
Open
0,91 US$
High
0,92 US$
Low
0,87 US$
Mkt. cap
241,36 მლნ.
Avg. vol.
8,26 მლნ.
Volume
3,12 ათ.
52-wk high
3,18 US$
52-wk low
0,81 US$
EPS
-0,11 US$
Beta
0,19
Shares outstanding
277,11 მლნ.
No. of employees
194
Open
0,91 US$
High
0,92 US$
Low
0,87 US$
Mkt. cap
241,36 მლნ.
Avg. vol.
8,26 მლნ.
Volume
3,12 ათ.
52-wk high
3,18 US$
52-wk low
0,81 US$
EPS
-0,11 US$
Beta
0,19
Shares outstanding
277,11 მლნ.
No. of employees
194
News stories
From web sources and news partners
Stock Titan
·
15 საათის წინ
A new hire's right to buy 8,400 Akebia shares phases in over four years, if they stay.
About Akebia Therapeutics Inc
CEO-
Employees194
Founded1 იან. 2007
Headquartersკემბრიჯი, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
Sector-
Websiteakebia.com